Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Watchful Waiting × Clear all

NCT03220009 2018-10-03

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Phase 2 Withdrawn

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms

NCT00632047 2013-08-26

Early Detection of Breast Cancer and Cervical Cancer in Women in India

Phase 2 Unknown

151,538 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms